This grant opportunity from the National Institutes of Health focuses on advancing precision genomic medicine by illuminating the genome related to Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The deadline for applications is May 19, 2026. Specific eligibility and funding details are not provided in the listing.
Eligibility details not specified in the grant listing. Contact the funding organization for requirements.